Newly Established Biotechnology Company Investment Opportunity in Haverhill, United States
Non-operational business offering CRO services and therapeutic protein distribution seeking funds to kick-start operations.
Premium Plan
| Established | 0-1 year(s) |
| Employees | 2 - 5 |
| Legal Entity | S Corporation |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Biotechnology |
| Locations | Haverhill |
| Local Time | 5:40 AM Etc / GMT+5 |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
1 million
for
10.0%
stake
(Native Currency: USD 1,000,000)
Reason: We need this investment for supporting and starting operations, we will accept investments in the ra...
View More
Includes physical assets worth
USD
250 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Documents
Certificate of Incorporation
(283.0 KB)
Business Overview
- The company is strategically positioned in the biotechnology sector, with plans to specialize in high-demand services such as flow cytometry and cell culture, tailored to support pharmaceutical, biotech, and diagnostic companies.
- Despite being registered 4 years ago, the company has yet to start operations but has laid the groundwork through strategic collaborations and grant submissions totalling approximately USD 40 million, showcasing a strong potential for funding acquisition.
- The promoter's extensive background, with a PhD in cell biology and two decades of research experience, provides a strong foundation for the company's technical expertise and leadership.
- Possession of distribution rights for crucial research kits and therapeutic proteins indicates early-stage readiness to supply essential products to the research community.
- The company maintains strategic collaborations with antibody-based firms, enhancing its capability to provide comprehensive solutions for advanced therapeutic and research needs.
- Haverhill, the company's location, provides access to a strategic geographical position that can facilitate partnerships with key biotech and pharmaceutical players.
- The planned service offerings, including advanced flow cytometry and specialized cell culture services, underscore the company's commitment to supporting cutting-edge research with reliable and customizable solutions.
- Despite being registered 4 years ago, the company has yet to start operations but has laid the groundwork through strategic collaborations and grant submissions totalling approximately USD 40 million, showcasing a strong potential for funding acquisition.
- The promoter's extensive background, with a PhD in cell biology and two decades of research experience, provides a strong foundation for the company's technical expertise and leadership.
- Possession of distribution rights for crucial research kits and therapeutic proteins indicates early-stage readiness to supply essential products to the research community.
- The company maintains strategic collaborations with antibody-based firms, enhancing its capability to provide comprehensive solutions for advanced therapeutic and research needs.
- Haverhill, the company's location, provides access to a strategic geographical position that can facilitate partnerships with key biotech and pharmaceutical players.
- The planned service offerings, including advanced flow cytometry and specialized cell culture services, underscore the company's commitment to supporting cutting-edge research with reliable and customizable solutions.
Products & Services Overview
The business will offer the following services:- CRO services:
- Flow cytometry: Will help gain deep insights into cellular processes and immune responses with our advanced flow cytometry services. We will offer comprehensive solutions, including cell profiling, sorting, functional assays, and drug screening, to support your research.
- Cell culture: We will specialize in cell line authentication, primary cell isolation, 3D models, and various cell-based assays. Our services will be customized to meet specific research needs, ensuring reliable, reproducible results.
We also hold distribution rights for a range of products, including research kits and therapeutic proteins, and collaborate with antibody-based companies to offer advanced solutions for research and therapeutic needs.
Our clients will be pharma companies, biotech companies and diagnostic companies.
Assets Overview
Tangible assets: lab equipment and the lab set-up.
Facilities Overview
Leased space around 850 square feet with access to research and diagnostic facilities such as cell culture, molecular and blood, infectious disease and drug toxicology testing.
Capitalization Overview
Self-funding.No loans/debt.
The business has 2 shareholders with 49% and 51% stakes.
Recent Activity
-
Earlier than 15 daysMD, Paris, Financial Consultant connected with the Business
-
Earlier than 15 daysSenior Investment Banking Executive, Investment Banking, Atlanta, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysConsultant, Odenton, Business Broker connected with the Business
Tags:
Newly Established Agricultural Biotechnology Company Investment Opportunity in Haverhill, United States
·Newly Established Biotech Facility Company Investment Opportunity in Haverhill, United States
·Newly Established Biotechnology Company Investment Opportunity in Haverhill, United States
·Invest in Newly Established Agricultural Biotechnology Company in Haverhill, United States
·Newly Established Biopharma Company Investment Opportunity in Haverhill, United States
·Invest in Newly Established Biotech Facility Company in Haverhill, United States
·Invest in Newly Established Biotechnology Company in Haverhill, United States
·Newly Established Agricultural Biotechnology Company Investment Opportunity
·Invest in Newly Established Biopharma Company in Haverhill, United States
·Newly Established Biotech Facility Company Investment Opportunity
·Newly Established Biotechnology Company Investment Opportunity
·Invest in Newly Established Agricultural Biotechnology Company
·Newly Established Biopharma Company Investment Opportunity
·Invest in Newly Established Biotech Facility Company
·Investment Opportunity in Haverhill, United States
·Invest in Newly Established Biotechnology Company
·Invest in Newly Established Biopharma Company
·Invest in Haverhill, United States
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
3 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 119,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses